Log in
Enquire now
‌

US Patent 7138500 Antibodies to human 4-1BB

Patent 7138500 was granted and assigned to Immunex on November, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Immunex
Immunex
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
71385000
Patent Inventor Names
Craig A. Smith0
Mark R. Alderson0
Raymond G. Goodwin0
Date of Patent
November 21, 2006
0
Patent Application Number
091512590
Date Filed
September 10, 1998
0
Patent Citations Received
‌
US Patent 11752207 Agonist antibodies that bind human CD137 and uses thereof
0
‌
US Patent 11851497 CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
0
Patent Primary Examiner
‌
Elizabeth Kemmerer
0
Patent abstract

Novel 4-1BB ligand (4-1BB-L) polypeptides and a human cell surface receptor designated 4-1BB that binds 4-1BB-L are provided. Isolated 4-1BB-L-encoding and human 4-1BB-encoding DNA sequences, recombinant expression vectors comprising the isolated DNA sequences, and host cells transformed with the recombinant expression vectors are disclosed, along with methods for producing the novel polypeptides by cultivating such transformed host cells. Soluble forms of the 4-1BB-L or 4-1BB polypeptides are derived from the extracellular domains thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7138500 Antibodies to human 4-1BB

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.